Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Patient Concerns About Deprescribing: How to Address Them

October 20, 2025

HMP · Patient Concerns About Deprescribing: How to Address Them

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD shares effective communication strategies with patients and caregivers.

Related Content

Can Anticholinergic Medications Make Movement Disorders Worse?
Why Should We Deprescribe Anticholinergics?
Assessing Anticholinergic Burden
Anticholinergic Misuse: Can These Medications Be Addictive?
Understanding the Cholinergic System
What’s the Role of Amantadine in Anticholinergic Deprescription?
Treatment Options and Managing Side Effects in Schizophrenia
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy